Guggenheim lowered the firm’s price target on Itron (ITRI) to $133 from $135 and keeps a Buy rating on the shares. Following a post-earnings catchup with management, the firm made some “small tweaks to our model,” notes the analyst, who continues to identify Itron as a “Best Idea.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
